Puma Biotechnology, Inc.
Clinical trials sponsored by Puma Biotechnology, Inc., explained in plain language.
-
New hope for Hard-to-Treat breast cancer: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug called alisertib combined with hormone therapy for people with a common type of advanced breast cancer (HR+, HER2-). It is for those whose cancer has worsened after at least two prior hormone treatments. The goal is to find the best dose and see if the…
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated May 26, 2026 07:32 UTC
-
New hope for tough lung cancer: alisertib trial targets resistant tumors
Disease control Recruiting nowThis study tests the drug alisertib in people with advanced small cell lung cancer whose disease has worsened after standard treatments like chemotherapy and immunotherapy. About 80 adults will take alisertib alone to see if it shrinks tumors or slows the cancer. The goal is to f…
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC